The role involves developing the global strategic plan and operational roadmap for the ETASi asset currently in Phase III development for Proteinuric CKD.
Base: $229,303 to $343,955 annually; Bonus/Equity: Short-term incentive bonus and long-term equity program eligible; Benefits: 401(k), paid vacation, holidays, medical, dental, vision coverage
Must-have
Nice-to-have
Not specified